NCT06452212Completed
Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients
A Non-Interventional, Modified Delphi Study to Establish Consensus Recommendations on the Optimal Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients in South Korea
Source: ClinicalTrials.gov · Last updated 21 Nov 2024
Brief summary (registry, in English)
The purpose of this study is to establish an expert consensus recommendations on managing patients with mHSPC in South Korea, and to provide clinicians with a comprehensive guide to support their clinical decision making. There are no secondary objectives for this study.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 23 (actual)
- First submitted
- 5 Jun 2024
- Start date
- 10 Jul 2024
- Primary completion date
- 29 Jul 2024
- Lead sponsor
- Astellas Pharma Korea, Inc.
- Diseases
- Prostate cancer
- NCT number
- NCT06452212
What you commit to
- Study type: Observational
- Participants enrolled: 23
- From 10 Jul 2024 to the primary completion date, 29 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Urologist in private practice.
Who the study is looking for
- Urologist from university hospitals in South Korea.
- Has a minimum 10 years of practice experience (experience as a military or public health doctor could be considered practice experience)
- Sees a minimum of 50 mHSPC patients in a year.
- At least 10 publications in SCIE (Science Citation Index Expanded) journals in the past 5 years.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| KR82001 Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.